The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVEC.L Share News (VEC)

  • There is currently no data for VEC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-No auction for Vectura as Carlyle declares $1.3 bln takeover bid final

Tue, 10th Aug 2021 17:02

(Recasts, adds detail, background)

By Yadarisa Shabong

Aug 10 (Reuters) - The takeover battle between tobacco giant
Philip Morris and private equity firm Carlyle for
inhaled treatments maker Vectura will not be heading to
the auction ring on Wednesday after Carlyle said it will not
raise its bid.

U.S.-based Carlyle on Tuesday declared final its 155 pence
per Vectura share offer, which it sweetened last week to value
the British company at about 958 million pounds ($1.33 billion).
The proposal is below an increased 165 pence bid from Philip
Morris on Sunday.

Britain's takeover regulator on Monday had intervened in the
battle, saying that it would enter a rare head-to-head auction https://www.reuters.com/world/uk/britains-takeover-regulator-intervenes-battle-drugmaker-vectura-2021-08-09
if the bidders do not make final bids by Tuesday 1600 GMT (1700
BST).

Only a handful of British takeover fights have gone to
auction, with the highest profile in recent years being the
battle in 2018 for pay-television group Sky when Comcast
emerged as the winner of a single-day three round
blind auction.

London-listed shares of Vectura closed at 163.4 pence on
Tuesday after hitting a more than five-year high of 176 pence
earlier in the session. They have gained 33% in value since
Carlyle's first offer in May.

Vectura has been the target of several approaches since May
from the U.S.-based groups, which are eyeing the drugmaker's
expertise with inhalable formulations and device designs for
respiratory therapies for illnesses such as asthma.

The London-listed company had voiced its support for the
Carlyle offer last week, saying that it may be better positioned
under the ownership of the private equity firm, while noting the
uncertainties that could arise for its stakeholders as a result
of being owned by the Marlboro cigarette-maker.

However, Vectura withdrew its backing and also withheld
support for the higher offer from Philip Morris following the
intervention from the Takeover Panel.

Vectura did not immediately respond to a request for
comment.

A deal with either one of the U.S. companies would require
shareholder approval.
($1 = 0.7229 pounds)

(Reporting by Yadarisa Shabong in Bengaluru; Editing by Shounak
Dasgupta and Lisa Shumaker)

More News
3 Oct 2019 15:59

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
26 Sep 2019 15:43

Vectura Senior Independent Non-Executive Foden Leaves, Werner Replaces

Vectura Senior Independent Non-Executive Foden Leaves, Werner Replaces

Read more
24 Sep 2019 12:56

Tuesday broker round up

(Sharecast News) - TUI: UBS upgrades to neutral with a target price of 900p.

Read more
11 Sep 2019 13:12

Wednesday broker round-up

(Sharecast News) - Renew Holdings: Peel Hunt initiates at buy with a target price of 500p.

Read more
11 Sep 2019 09:31

BROKER RATINGS SUMMARY: HSBC Downgrades Shell To Hold From Buy

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:----------FTSE 100----------HSBC CUTS ROYAL DUTCH SHELL TO - BP

Read more
10 Sep 2019 10:17

Vectura Proposes Capital Return Amid "Strong" Interim Revenue Growth

(Alliance News) - Drug development firm Vectura Group PLC proposed a special dividend and buyback Tuesday after reporting revenue jumped on a strong inhaler performance with losses the six months

Read more
3 Sep 2019 16:17

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 4 September Oxford BiomedicaHalf Year ResultsDunelm GroupFull Year Year Income

Read more
17 Jul 2019 10:16

Vectura Confirms Annual Outlook; Plans GBP50 Million Shareholder Award

(Alliance News) - Vectura Group PLC on Wednesday confirmed its research & development investment priorities and proposed a GBP50 million capital return.The pharmaceutical company said a

Read more
17 Jul 2019 08:35

LONDON MARKET OPEN: Fresnillo, Johnson Matthey Help Pull FTSE 100 Down

(Alliance News) - Stocks began the day lower in London on Wednesday, with Fresnillo and Johnson Matthey failing to please investors, though there were a number of

Read more
10 Jun 2019 09:13

Vectura Chief Executive To Leave; Finance Head Named As Interim CEO

LONDON (Alliance News) - Vectura Group PLC on Monday said Chief Executive James Ward-Lilley will be stepping down at the end of June.Paul Fry, chief financial officer, will assume the role

Read more
10 Jun 2019 07:41

LONDON MARKET PRE-OPEN: Vectura And MJ Gleeson CEOs Leave

LONDON (Alliance News) - Stock prices in London are seen opening higher on Monday after US President Donald Trump suspended his plans for tariffs on Mexico, while hopes of lower US interest rates

Read more
29 May 2019 14:41

Vectura trading in line, mulling capital returns

(Sharecast News) - Vectura confirmed on Wednesday that its outlook remains in line with guidance for the full year as it said it was considering returning some capital to shareholders.

Read more
29 May 2019 13:44

Wednesday broker round-up

(Sharecast News) - Serco: RBC Capital Markets upgrades to outperform with a target price of 150p.

Read more
29 May 2019 10:01

Vectura Group On Track, Confident On Prospects For Rest Of 2019

LONDON (Alliance News) - Pharmaceutical firm Vectura Group PLC said at its annual general meeting Wednesday it is on track to meet full year guidance.In March, the firm reported a slightly

Read more
24 May 2019 09:35

Vectura Gets Milestone Payment On Novartis Submission Of Asthma Drug

LONDON (Alliance News) - Pharmaceutical company Vectura Group PLC said it is to receive a USD2.5 million milestone payment from Novartis AG relating to possible new asthma therapy filed a with EU

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.